Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Guillet, FR

Alain Guillet, Blagnac FR

Patent application numberDescriptionPublished
20080294306METHOD AND DEVICE FOR MONITORING A POSITION INDICATION OF AN AIRCRAFT - The device (11-27-2008
20100169005METHOD AND DEVICE FOR DETERMINING A CONSOLIDATED POSITION OF A TRAVELING OBJECT, PARTICULARLY AN AIRCRAFT - The invention relates to a method and device for determining a consolidated position of a travelling object, particularly an aircraft. The device (07-01-2010
20100169014METHOD AND DEVICE FOR DETERMINING A RELIABLE POSITION OF AN AIRCRAFT - The invention relates to a method and device for determining a reliable position of an aircraft. The device (07-01-2010

Benjamin Guillet, Aix-En-Provence FR

Patent application numberDescriptionPublished
20110286963HUMAN SOLUBLE CD146, PREPARATION AND USES THEREOF - The present invention relates to compositions and methods for modulating angiogenesis in vivo, ex vivo or in vitro. More particularly, the invention relates to a soluble CD 146 protein usable in the context of human therapy, as well as to corresponding antibodies. Particular forms of CD 146, herein described, may be used to mobilize, in vivo or ex vivo, both mature and immature endothelial cells, as well as to increase their influence on angiogenesis. The invention also relates to compositions comprising such compounds, particularly pharmaceutical or diagnostic compositions, including kits and the like, as well as methods of therapy or diagnosis using said compounds, compositions and cells.11-24-2011

Dominique Guillet, Vernaison FR

Patent application numberDescriptionPublished
20100305370METHOD FOR PREPARING 2,3,3,3-TETRAFLUORO-1-PROPENE - The invention relates to a gas-phase continuous method for preparing 2,3,3,3-tetrafluoro-1-propene, said method comprising the following steps: (i) hydrogenation of hexafluoropropylene to form 1,1,1,2,3,3-hexafluoropropane; (ii) dehydrofluorination of the 1,1,1,2,3,3-hexafluoropropane obtained in the previous step to 1,2,3,3,3-pentafluoropropene-1; (iii) hydrogenation of the 1,2,3,3,3-pentafluoropropene-1 obtained in the previous step to form 1,1,1,2,3-pentafluoropropane; and (iv) dehydrofluorination of the 1,1,1,2,3-pentafluoropropane obtained in the previous step to form 2,3,3,3-tetrafluoro-1-propene.12-02-2010

Emmanuel Guillet, Plaisance Du Touch FR

Patent application numberDescriptionPublished
20100116926DEVICE FOR ATTACHING AN AIRCRAFT ENGINE AND AIRCRAFT COMPRISING AT LEAST ONE SUCH DEVICE - A device for attaching an aircraft engine including a thrust force take-up device that includes a main fitting to be fixed to an engine mounting beam fixed to a box structure, an additional fitting fixed to the main fitting, and two load reacting link rods connected to the main fitting by a balance beam, each of the link rods being connected to the balance beam by a first longitudinal end by a first mechanical connection that has at least one axis of rotation, each of the link rods being connected to the additional fitting by a second longitudinal end by a second mechanical connection that has at least one axis of rotation, the second mechanical connection having play, the first and second mechanical connections having at least one axis of rotation in common.05-13-2010
20110114786DEVICE FOR ATTACHING AN AIRCRAFT ENGINE COMPRISING A THRUST FORCE TAKE-UP DEVICE WITH A COMPACT DESIGN - An aircraft engine attachment device including a rigid structure and a mechanism attaching the engine on the rigid structure, the attachment mechanism including a rear engine attachment and a device for taking-up thrust forces generated by the engine. The rear engine attachment is attached to the rigid structure by two lateral fittings attached to the rigid structure. The force take-up device includes two connecting rods mechanically connected to a spreader beam by a mechanical connection, a connection fitting attached to the rear engine attachment and mechanically connected to the rigid structure by a thrust pin, the lateral fittings including a stop mechanism to limit pivoting of the spreader beam if a connecting rod breaks and ensuring transmission of thrust forces to the rigid structure.05-19-2011

Jacques Guillet, L'Arbresle FR

Patent application numberDescriptionPublished
20110288190METHOD FOR TREATING A MATERIAL DERIVED FROM RECOVERY AND GRINDING - A method of treating a material derived from recovery and shredding, the material comprising a mixture of polypropylene and polyethylene, wherein the material is mixed with 1% to 5% by weight of copolymer of ethylene-α-olefin type.11-24-2011

Jean-Gerard Guillet, Paris FR

Patent application numberDescriptionPublished
20080213818CELLULAR IMMUNITY TEST WITH PEPTIDES ATTACHED TO A SOLID SUPPORT - The invention concerns a method for detecting cellular immunity (with respect to an antigen), using a solid support whereon is fixed an assortment of peptides constituting T cell epitopes of the antigen to be tested, kits for implementing said method.09-04-2008
20080248044POLYEPITOPIC PROTEIN FRAGMENTS OF THE E6 AND E7 PROTEINS OF HPV, THEIR PRODUCTION AND THEIR USE PARTICULARLY IN VACCINATION - Polyepitopic peptides of E6 and E7 proteins of Human Papillomavirus, their production, and methods of treating pathologies in which a polyepitopic peptide of the E6 and E7 protein of Human Papillomavirus is recognized by the cellular immune system.10-09-2008
20100047333Modified Peptides and Their Use for the Treatment of Autoimmune Diseases - Disclosed herein are a modified peptide, compositions containing the same and their use in the treatment of autoimmune diseases. The modified peptide is provided by a chemical modification of at least one of the several amino acid residues comprising the peptide. The modification is carried out by phosphorylation, acetylation or methylation, or as a combination thereof.02-25-2010
20100203080Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof - The invention concerns a mixture of peptides derived from the E6 and/or E7 proteins of a papillomavirus involved in cervix of uterus cancer, such as HPV16, HPV18, HPV30, HPV31, HPV32, HPV33, HPV34, HPV35, HPV39, HPV40, HPV42, HPV43, HPV44, HPV45, HPV51, HPV52, HPV56, HPV57, and HPV58, for example, as well as its uses as medicine (in immunogenic compositions, capable of stimulating the production of anti-HPV T CD4+ lymphocytes in vivo and hence useful for vaccination against uterine of uterus cancer and in other cancers) or as diagnostic reagent of HPV-specific T lymphocytes, in particular for assessing the immune condition of patients. The invention also concerns a mixture of peptides derived from E6 and/or E7 proteins of a papillomavirus involved in benign skin lesions (for example warts), such as HPV10, HPV3 or HPV4 and its uses as medicine.08-12-2010

Patent applications by Jean-Gerard Guillet, Paris FR

Jean-Gérard Guillet, Paris FR

Patent application numberDescriptionPublished
20110171250Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines - The invention relates to a synthetic gene coding for the Gag protein of the human immunodeficiency virus HIV-1. Said gene may optionally be fused with one or more other HIV sequences. The invention may notably be used within the scope of obtaining anti-HIV vaccines.07-14-2011

Marina Guillet, Blain FR

Patent application numberDescriptionPublished
20100304988DIAGNOSTIC OF IMMUNE GRAFT TOLERANCE - The present invention concerns a method for the in vitro diagnosis of a graft tolerant phenotype, comprising: determining from a grafted subject biological sample an expression profile comprising, or consisting of, 8 genes, and optionally at least one among 41 further genes, identified in the present invention as differentially expressed between graft tolerant subjects and subjects in chronic rejection, optionally measuring other parameters, and determining the presence or absence of a graft tolerant phenotype from said expression profile and optional other parameters. Said method may further comprise, if said subject is diagnosed as a graft non-tolerant subject, diagnosing from the expression profile if said subject is developing chronic rejection. The invention further concerns kits and oligonucleotide microarrays suitable to implement said method.12-02-2010

Nicolas Guillet, Chatuzange Le Goubet FR

Patent application numberDescriptionPublished
20090155643Method for using a fuel cell comprising a regeneration step by lowering the temperature - The fuel cell supplies power to a load under nominal conditions. The method for using the fuel cell comprises at least one regeneration step of the performances of the cell by temporarily lowering its temperature below the nominal operating temperature. The regeneration step, performed during a preset time, can be triggered periodically or when the voltage at the terminals of the cell or the cell temperature is lower than a threshold. The performances of the cell, in particular its voltage, can thereby be maintained substantially constant during long periods of use.06-18-2009
20110240488DEVICE FOR DETERMINING CARBON MONOXIDE CONCENTRATION AND RELATED METHOD - The invention relates to a device for determining the CO concentration in a gas containing hydrogen, said device comprising a detection electrode (10-06-2011

Pascal Guillet, Luisant FR

Patent application numberDescriptionPublished
20090305582Male electrical terminal - This terminal includes a folded contact section which has a longitudinal junction line and defines contact surfaces, a securing section, suitable to be accommodated in a terminal accommodating chamber of an insulating housing, and an intermediate section extending between said contact section and securing section. The intermediate section is deformed in torsion around the longitudinal axis (X), whereby the junction line is angularly offset from the contact surfaces around the longitudinal axis (X). The invention also relates to a process for manufacturing such a terminal, and to an electrical connector including such a terminal.12-10-2009

Thomas Guillet, Paris FR

Patent application numberDescriptionPublished
20110246770AUTHENTICATION METHOD, AUTHENTICATION SYSTEM, SERVER TERMINAL, CLIENT TERMINAL AND COMPUTER PROGRAMS THEREFOR - An authentication method between a client (10-06-2011